Spanish-born astronaut López-Alegría leads Axiom's Ax-3 commercial mission to ISS

Miguel López-Alegría, sixty-five years old and born in Madrid, was strapping in for his second trip to orbit. On Wednesday, January 17th, at 10:11 p.m. Eastern time, a SpaceX Falcon 9 rocket would lift him and three other astronauts from Kennedy Space Center in Florida, carrying them toward the International Space Station aboard a Dragon capsule. For López-Alegría, the moment carried particular weight. He had already made history once—as the first person born in Spain to reach space—and now he was returning as commander of Axiom Space's third commercial mission to the orbiting laboratory.

The crew he was leading represented a deliberate statement about the future of spaceflight. Alongside him would be Walter Villadei, a pilot from Italy's air force; Alper Gezeravcı, a mission specialist from Turkey who would become the first Turkish citizen in space; and Marcus Wandt, a Swedish astronaut with the European Space Agency. This was the first Axiom mission to carry the ESA's official sponsorship, a partnership that signaled something larger than a single flight—it was a step toward Axiom's stated goal of building the world's first commercial space station. The European Space Agency, which already pours eight billion dollars annually into the ISS, was betting on the private sector's ability to sustain human spaceflight beyond government programs.

López-Alegría's path to this moment had been methodical and long. He graduated from the Naval Academy in 1980 with a degree in systems engineering, then continued his education at the Naval Postgraduate School and earned a master's in aerospace engineering. He later completed an executive program in national and international security at Harvard Kennedy School. Between 1995 and 2007, he flew on five space missions—three on the Space Shuttle and two aboard Russian Soyuz spacecraft. When he commanded Axiom's first commercial mission, Ax-1, in November 2023, he shared the capsule with a billionaire from the United States, an Israeli businessman, and a Canadian investor. That seventeen-day flight had included scientific experiments, commercial activities, STEM education initiatives, and something novel: the crew wore brain-reading helmets that allowed researchers to study their neural activity in microgravity.

The Ax-3 mission would follow a similar template but with a different focus. The four astronauts would spend fourteen days aboard the station conducting research that Axiom and its partners had carefully selected. Two studies stood out: both involved stem cells and both were led by the Stanford Stem Cell Institute at UC San Diego. One would examine tumor organoids in microgravity to identify early warning signs of cancer. The other would analyze changes in blood enzymes during and after spaceflight to better understand their role in health and disease. The research represented the kind of work that commercial spaceflight advocates argue can only happen in the unique environment of low Earth orbit—where gravity's pull vanishes and biological processes behave in ways impossible to replicate on the ground.

But the mission also illustrated the economic reality of commercial spaceflight. Each seat on Ax-3 cost approximately fifty-five million dollars—roughly the same price Axiom had charged for Ax-1, despite the company's stated intention to lower costs as flights became more routine. On top of the seat price, the ESA would pay for food, waste disposal, cargo launches, crew time, and the integration of experiments. Food alone ran two thousand dollars per person per day. Passive cargo cost twenty thousand dollars per kilogram. Waste removal cost the same. The total bill for the mission was substantial, and there was no guarantee that future pricing would improve. Matt Ondler, Axiom's president, had been blunt about it: Ax-3 was not cheaper than Ax-1.

Yet the ESA had committed anyway. The agency saw something worth the expense—not just the immediate science, but the precedent. By sponsoring a commercial mission and flying European astronauts on a private spacecraft, the ESA was signaling that the future of human spaceflight would be mixed, with government agencies and private companies working in tandem. López-Alegría, when asked at a press conference whether he would fly with Axiom again, had answered simply: yes, as long as his body allowed it. The question now was whether the economics of commercial spaceflight would allow the rest of the world to say the same.